Nanomedicine is the application of nanotechnology for the treatment, diagnosis, monitoring, and control of biological systems. Nanomedicines hold great promise for addressing some of the most challenging problems in nearly every medical specialty, and this nascent field has the potential to generate many new opportunities for improving human health. However, there are also concerns that the fundamentally different properties of nanoparticles compared with bulk materials may pose significant safety issues, and therefore require additional regulatory scrutiny.
As such, this conference will focus on the following topics:
- Current US and international regulatory frameworks for nanomedicines, and the future needs ahead;
- Additional safety and toxicity research needed to determine unknown properties of nanomaterials; and
- Lessons learned from featured drug development case studies of nanomedicines.
The conference will conclude with a panel discussion to bring together both scientific and regulatory perspectives to help guide future communication and action.
Early Bird registration has been extended until October 31.
|Nonmember (Student / Postdoc / Fellow)